Rank | Gene Set | Z-score |
---|---|---|
1 | branching involved in prostate gland morphogenesis (GO:0060442) | 7.65935417 |
2 | opsonization (GO:0008228) | 6.81552327 |
3 | iron ion import (GO:0097286) | 5.58549401 |
4 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 5.57892205 |
5 | carnitine shuttle (GO:0006853) | 5.52073726 |
6 | artery development (GO:0060840) | 5.31379962 |
7 | prostate gland epithelium morphogenesis (GO:0060740) | 4.94229501 |
8 | fatty acid transmembrane transport (GO:1902001) | 4.84375856 |
9 | epithelial cell maturation (GO:0002070) | 4.79789691 |
10 | positive regulation of macrophage cytokine production (GO:0060907) | 4.64891736 |
11 | regulation of receptor binding (GO:1900120) | 4.62944083 |
12 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.22407996 |
13 | carnitine transmembrane transport (GO:1902603) | 4.18465988 |
14 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.10930387 |
15 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 4.01512778 |
16 | Golgi to endosome transport (GO:0006895) | 3.95765209 |
17 | intestinal epithelial cell development (GO:0060576) | 3.91514285 |
18 | carnitine transport (GO:0015879) | 3.87846248 |
19 | amino-acid betaine transport (GO:0015838) | 3.87846248 |
20 | quaternary ammonium group transport (GO:0015697) | 3.68179877 |
21 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.67647511 |
22 | import into cell (GO:0098657) | 3.60917452 |
23 | response to testosterone (GO:0033574) | 3.49895818 |
24 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.48308539 |
25 | epoxygenase P450 pathway (GO:0019373) | 3.48067817 |
26 | pharyngeal system development (GO:0060037) | 3.44097511 |
27 | omega-hydroxylase P450 pathway (GO:0097267) | 3.43230126 |
28 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.43093988 |
29 | positive regulation of steroid hormone secretion (GO:2000833) | 3.32445462 |
30 | lung epithelial cell differentiation (GO:0060487) | 3.30180214 |
31 | mitotic cell cycle arrest (GO:0071850) | 3.23162468 |
32 | lung cell differentiation (GO:0060479) | 3.22796116 |
33 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22143919 |
34 | regulation of protein polyubiquitination (GO:1902914) | 3.21720647 |
35 | L-serine metabolic process (GO:0006563) | 3.21244551 |
36 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.20660331 |
37 | valine metabolic process (GO:0006573) | 3.16794611 |
38 | coenzyme A metabolic process (GO:0015936) | 3.12463533 |
39 | exogenous drug catabolic process (GO:0042738) | 3.10394539 |
40 | vocalization behavior (GO:0071625) | 3.06686161 |
41 | regulation of plasminogen activation (GO:0010755) | 3.05875021 |
42 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.05183885 |
43 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.04850900 |
44 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.04840209 |
45 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.00631609 |
46 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.98718416 |
47 | coenzyme A biosynthetic process (GO:0015937) | 2.96045770 |
48 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.92596188 |
49 | drug catabolic process (GO:0042737) | 2.90060433 |
50 | presynaptic membrane assembly (GO:0097105) | 2.84660817 |
51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.82571030 |
52 | lung lobe morphogenesis (GO:0060463) | 2.81314402 |
53 | endothelial cell chemotaxis (GO:0035767) | 2.80784621 |
54 | thioester biosynthetic process (GO:0035384) | 2.80631724 |
55 | acyl-CoA biosynthetic process (GO:0071616) | 2.80631724 |
56 | anterior/posterior axis specification, embryo (GO:0008595) | 2.79005345 |
57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.78993403 |
58 | positive regulation of histone deacetylation (GO:0031065) | 2.78264312 |
59 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.77576035 |
60 | basement membrane organization (GO:0071711) | 2.76546491 |
61 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.74339163 |
62 | neuronal action potential propagation (GO:0019227) | 2.71583471 |
63 | endoplasmic reticulum organization (GO:0007029) | 2.70602108 |
64 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.69909923 |
65 | negative regulation of cell size (GO:0045792) | 2.68215779 |
66 | purine nucleotide transport (GO:0015865) | 2.66790404 |
67 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.66781608 |
68 | apical protein localization (GO:0045176) | 2.66628991 |
69 | auditory receptor cell differentiation (GO:0042491) | 2.66434181 |
70 | negative regulation of DNA repair (GO:0045738) | 2.66049914 |
71 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.65730794 |
72 | negative regulation of fatty acid transport (GO:2000192) | 2.65660509 |
73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.64733755 |
74 | L-phenylalanine catabolic process (GO:0006559) | 2.64733755 |
75 | regulation of female receptivity (GO:0045924) | 2.64648412 |
76 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.63279055 |
77 | regulation of ARF protein signal transduction (GO:0032012) | 2.63036421 |
78 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.62002723 |
79 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.62002723 |
80 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.62002723 |
81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.61576659 |
82 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.60657231 |
83 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.60269660 |
84 | sulfur amino acid catabolic process (GO:0000098) | 2.59684082 |
85 | piRNA metabolic process (GO:0034587) | 2.59241487 |
86 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 2.58861636 |
87 | glutamate secretion (GO:0014047) | 2.58517647 |
88 | intracellular lipid transport (GO:0032365) | 2.57811354 |
89 | cysteine metabolic process (GO:0006534) | 2.56303956 |
90 | regulation of macrophage cytokine production (GO:0010935) | 2.55925524 |
91 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.55827715 |
92 | neurotransmitter catabolic process (GO:0042135) | 2.53531879 |
93 | neuron cell-cell adhesion (GO:0007158) | 2.53521180 |
94 | short-chain fatty acid metabolic process (GO:0046459) | 2.52927622 |
95 | oxidative demethylation (GO:0070989) | 2.52919231 |
96 | negative regulation of glycogen metabolic process (GO:0070874) | 2.52707584 |
97 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.52383440 |
98 | ethanol oxidation (GO:0006069) | 2.50200416 |
99 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.49282124 |
100 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.48518780 |
101 | complement activation, alternative pathway (GO:0006957) | 2.46701865 |
102 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.46566585 |
103 | presynaptic membrane organization (GO:0097090) | 2.46534756 |
104 | protein localization to synapse (GO:0035418) | 2.45283631 |
105 | negative regulation of lipase activity (GO:0060192) | 2.45275857 |
106 | phenol-containing compound catabolic process (GO:0019336) | 2.44803402 |
107 | glutamate receptor signaling pathway (GO:0007215) | 2.44061193 |
108 | serine family amino acid biosynthetic process (GO:0009070) | 2.42314196 |
109 | response to phenylpropanoid (GO:0080184) | 2.40894937 |
110 | positive regulation of fatty acid oxidation (GO:0046321) | 2.40820402 |
111 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 2.40630728 |
112 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.39971272 |
113 | L-phenylalanine metabolic process (GO:0006558) | 2.39971272 |
114 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.38295458 |
115 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.38110466 |
116 | membrane assembly (GO:0071709) | 2.37282489 |
117 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.37086578 |
118 | female mating behavior (GO:0060180) | 2.37012691 |
119 | succinate metabolic process (GO:0006105) | 2.35513263 |
120 | branched-chain amino acid metabolic process (GO:0009081) | 2.33900657 |
121 | regulation of glutamate secretion (GO:0014048) | 2.33757829 |
122 | aromatic amino acid family catabolic process (GO:0009074) | 2.33068340 |
123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.31893189 |
124 | oxaloacetate metabolic process (GO:0006107) | 2.29506992 |
125 | drug transmembrane transport (GO:0006855) | 2.27940718 |
126 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.25877163 |
127 | mating behavior (GO:0007617) | 2.25496900 |
128 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.25340929 |
129 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.22048366 |
130 | neurotransmitter secretion (GO:0007269) | 2.20471702 |
131 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.20430048 |
132 | fatty acid oxidation (GO:0019395) | 2.20157462 |
133 | bile acid biosynthetic process (GO:0006699) | 2.20105292 |
134 | ethanol metabolic process (GO:0006067) | 2.19916969 |
135 | negative regulation of dendrite development (GO:2000171) | 2.19836293 |
136 | protein targeting to Golgi (GO:0000042) | 2.18415811 |
137 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.18005776 |
138 | desmosome organization (GO:0002934) | 2.17673818 |
139 | glutamate metabolic process (GO:0006536) | 2.17038395 |
140 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.16910285 |
141 | cellular ketone body metabolic process (GO:0046950) | 2.16310605 |
142 | branched-chain amino acid catabolic process (GO:0009083) | 2.15999006 |
143 | cellular modified amino acid catabolic process (GO:0042219) | 2.15512959 |
144 | behavioral response to cocaine (GO:0048148) | 2.15472490 |
145 | response to histamine (GO:0034776) | 2.15402225 |
146 | lipid oxidation (GO:0034440) | 2.14915886 |
147 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.13959916 |
148 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.12152242 |
149 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.11267447 |
150 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.10525478 |
151 | positive regulation of respiratory burst (GO:0060267) | 2.08628396 |
152 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.08240274 |
153 | regulation of postsynaptic membrane potential (GO:0060078) | 2.07852745 |
154 | indole-containing compound catabolic process (GO:0042436) | 2.07798153 |
155 | indolalkylamine catabolic process (GO:0046218) | 2.07798153 |
156 | tryptophan catabolic process (GO:0006569) | 2.07798153 |
157 | kynurenine metabolic process (GO:0070189) | 2.07478863 |
158 | acylglycerol catabolic process (GO:0046464) | 2.06886770 |
159 | neutral lipid catabolic process (GO:0046461) | 2.06886770 |
160 | synaptic vesicle exocytosis (GO:0016079) | 2.05111333 |
161 | high-density lipoprotein particle remodeling (GO:0034375) | 2.05011365 |
162 | benzene-containing compound metabolic process (GO:0042537) | 2.04492461 |
163 | tryptophan metabolic process (GO:0006568) | 2.04422323 |
164 | postsynaptic membrane organization (GO:0001941) | 2.04274406 |
165 | regulation of protein kinase A signaling (GO:0010738) | 2.03448944 |
166 | glyoxylate metabolic process (GO:0046487) | 2.02895444 |
167 | fatty acid catabolic process (GO:0009062) | 2.02825171 |
168 | suckling behavior (GO:0001967) | 2.02502297 |
169 | glucocorticoid metabolic process (GO:0008211) | 2.02075741 |
170 | triglyceride catabolic process (GO:0019433) | 2.01983758 |
171 | alpha-linolenic acid metabolic process (GO:0036109) | 2.01840347 |
172 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.00929879 |
173 | neuron-neuron synaptic transmission (GO:0007270) | 2.00237498 |
174 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 1.99997678 |
175 | very long-chain fatty acid metabolic process (GO:0000038) | 1.99379149 |
176 | amino-acid betaine metabolic process (GO:0006577) | 1.98924314 |
177 | fatty acid beta-oxidation (GO:0006635) | 1.98765698 |
178 | biotin metabolic process (GO:0006768) | 1.98740976 |
179 | proline transport (GO:0015824) | 1.97961023 |
180 | positive regulation of vesicle fusion (GO:0031340) | 1.97824130 |
181 | innervation (GO:0060384) | 1.97745739 |
182 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 1.97024349 |
183 | negative regulation of protein autophosphorylation (GO:0031953) | 1.95989829 |
184 | acetyl-CoA metabolic process (GO:0006084) | 1.95633193 |
Rank | Gene Set | Z-score |
---|---|---|
1 | AR_21909140_ChIP-Seq_LNCAP_Human | 5.36375488 |
2 | CHD1_26751641_Chip-Seq_LNCaP_Human | 3.25067875 |
3 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 3.20360613 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.11698290 |
5 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 3.11056430 |
6 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 3.08869883 |
7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.05084502 |
8 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.75856238 |
9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.68093621 |
10 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47340929 |
11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40407553 |
12 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32980044 |
13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29517926 |
14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23692596 |
15 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.23608398 |
16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.20467613 |
17 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.19757773 |
18 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12357330 |
19 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12357330 |
20 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04797966 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.02973898 |
22 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01127954 |
23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.00700220 |
24 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99913629 |
25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96697073 |
26 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92392194 |
27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89950846 |
28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82214421 |
29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80820127 |
30 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.79864035 |
31 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.79799954 |
32 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78013276 |
33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77120262 |
34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75983564 |
35 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.75657153 |
36 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.75657153 |
37 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.75657153 |
38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73875824 |
39 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.72907354 |
40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70794079 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70731394 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68543489 |
43 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65695815 |
44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62983925 |
45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62947236 |
46 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.60483577 |
47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59023933 |
48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58076409 |
49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55140366 |
50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54420133 |
51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53741997 |
52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52627465 |
53 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.52571058 |
54 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51974791 |
55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51328437 |
56 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51200775 |
57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50191624 |
58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49690792 |
59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49145140 |
60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47230465 |
61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.46024186 |
62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45841775 |
63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43741896 |
64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43337966 |
65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42931989 |
66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42654408 |
67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42620737 |
68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41538335 |
69 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.41141825 |
70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.40033880 |
71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39892939 |
72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38749615 |
73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38749615 |
74 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38344932 |
75 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38064441 |
76 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.37999411 |
77 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.34499547 |
78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34125093 |
79 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34095540 |
80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32884037 |
81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32861349 |
82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32786126 |
83 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.32671593 |
84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32182312 |
85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.31488104 |
86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31223522 |
87 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.31121719 |
88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30381787 |
89 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29175968 |
90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28536280 |
91 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.27749829 |
92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27182093 |
93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26918871 |
94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25599189 |
95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25431866 |
96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25318622 |
97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.25204752 |
98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24907316 |
99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22222835 |
100 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22147057 |
101 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.21797443 |
102 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21753129 |
103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21553681 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21089471 |
105 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20676592 |
106 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19649496 |
107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18204272 |
108 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18201370 |
109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17392371 |
110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17224104 |
111 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16372914 |
112 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14643285 |
113 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14540743 |
114 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13570788 |
115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13331749 |
116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12146673 |
117 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.11960536 |
118 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11831176 |
119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.10760075 |
120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08725799 |
121 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07798348 |
122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07724329 |
123 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07184692 |
124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06797565 |
125 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06784299 |
126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.03759233 |
127 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.03759233 |
128 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.03048372 |
129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01748772 |
130 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01029473 |
131 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.00518349 |
132 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99763414 |
133 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99683886 |
134 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99050925 |
135 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98969175 |
136 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98882088 |
137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97155329 |
138 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97140909 |
139 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96425001 |
140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96102333 |
141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95029327 |
142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94692073 |
143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94404932 |
144 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.94271874 |
145 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93791563 |
146 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93670494 |
147 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93434471 |
148 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92841563 |
149 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92581963 |
150 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92580644 |
151 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92367038 |
152 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91706515 |
153 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.91437404 |
154 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91437404 |
155 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90705209 |
156 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.90509314 |
157 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90006444 |
158 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89745915 |
159 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89731314 |
160 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89602460 |
161 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88862646 |
162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88781316 |
163 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88066668 |
164 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87288499 |
165 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.85949657 |
166 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84989161 |
167 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81214316 |
168 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.81163523 |
169 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80102462 |
170 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80064854 |
171 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79362326 |
172 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77658721 |
173 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.76930025 |
174 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.75871711 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 3.39772660 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.25198751 |
3 | MP0003283_abnormal_digestive_organ | 3.08308461 |
4 | MP0003705_abnormal_hypodermis_morpholog | 2.97729806 |
5 | MP0004233_abnormal_muscle_weight | 2.87382682 |
6 | MP0005645_abnormal_hypothalamus_physiol | 2.79440756 |
7 | MP0005275_abnormal_skin_tensile | 2.77256470 |
8 | MP0010386_abnormal_urinary_bladder | 2.72922343 |
9 | MP0005360_urolithiasis | 2.70172445 |
10 | MP0004859_abnormal_synaptic_plasticity | 2.67684636 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.60604065 |
12 | MP0002234_abnormal_pharynx_morphology | 2.59872080 |
13 | MP0002876_abnormal_thyroid_physiology | 2.56714736 |
14 | MP0009780_abnormal_chondrocyte_physiolo | 2.56537859 |
15 | MP0004185_abnormal_adipocyte_glucose | 2.43815197 |
16 | MP0005310_abnormal_salivary_gland | 2.39660796 |
17 | MP0003195_calcinosis | 2.39326975 |
18 | MP0005367_renal/urinary_system_phenotyp | 2.33210684 |
19 | MP0000516_abnormal_urinary_system | 2.33210684 |
20 | * MP0002166_altered_tumor_susceptibility | 2.33142251 |
21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.28343284 |
22 | MP0001501_abnormal_sleep_pattern | 2.27763574 |
23 | MP0001968_abnormal_touch/_nociception | 2.22287513 |
24 | MP0002837_dystrophic_cardiac_calcinosis | 2.20428036 |
25 | MP0003635_abnormal_synaptic_transmissio | 2.12467722 |
26 | MP0005451_abnormal_body_composition | 2.12242389 |
27 | MP0009745_abnormal_behavioral_response | 2.03200045 |
28 | MP0002736_abnormal_nociception_after | 1.94651733 |
29 | MP0005365_abnormal_bile_salt | 1.88815806 |
30 | MP0006276_abnormal_autonomic_nervous | 1.86921600 |
31 | MP0004270_analgesia | 1.83015046 |
32 | MP0000751_myopathy | 1.81650643 |
33 | MP0008961_abnormal_basal_metabolism | 1.80668745 |
34 | MP0005085_abnormal_gallbladder_physiolo | 1.78996101 |
35 | MP0009046_muscle_twitch | 1.78038274 |
36 | MP0010234_abnormal_vibrissa_follicle | 1.75803608 |
37 | MP0010329_abnormal_lipoprotein_level | 1.70501088 |
38 | MP0002063_abnormal_learning/memory/cond | 1.69876215 |
39 | MP0005503_abnormal_tendon_morphology | 1.68654021 |
40 | MP0002254_reproductive_system_inflammat | 1.66377919 |
41 | MP0003123_paternal_imprinting | 1.63561377 |
42 | MP0000013_abnormal_adipose_tissue | 1.63372725 |
43 | MP0004130_abnormal_muscle_cell | 1.62394215 |
44 | MP0002064_seizures | 1.61391119 |
45 | MP0001873_stomach_inflammation | 1.59081118 |
46 | MP0009053_abnormal_anal_canal | 1.58078810 |
47 | MP0005076_abnormal_cell_differentiation | 1.55571583 |
48 | MP0005220_abnormal_exocrine_pancreas | 1.53467844 |
49 | MP0002272_abnormal_nervous_system | 1.52861145 |
50 | * MP0000537_abnormal_urethra_morphology | 1.52082242 |
51 | MP0002572_abnormal_emotion/affect_behav | 1.52058817 |
52 | MP0000534_abnormal_ureter_morphology | 1.51458739 |
53 | MP0001661_extended_life_span | 1.50371759 |
54 | MP0005670_abnormal_white_adipose | 1.50098983 |
55 | MP0002796_impaired_skin_barrier | 1.47258279 |
56 | MP0005332_abnormal_amino_acid | 1.45950549 |
57 | MP0002735_abnormal_chemical_nociception | 1.44890037 |
58 | * MP0004145_abnormal_muscle_electrophysio | 1.41961319 |
59 | MP0000566_synostosis | 1.41652572 |
60 | MP0005535_abnormal_body_temperature | 1.39801726 |
61 | MP0001765_abnormal_ion_homeostasis | 1.38845381 |
62 | MP0005647_abnormal_sex_gland | 1.37653906 |
63 | * MP0002006_tumorigenesis | 1.35823545 |
64 | MP0000613_abnormal_salivary_gland | 1.34016783 |
65 | MP0003942_abnormal_urinary_system | 1.33867404 |
66 | MP0004272_abnormal_basement_membrane | 1.33529550 |
67 | MP0004019_abnormal_vitamin_homeostasis | 1.33290758 |
68 | MP0001984_abnormal_olfaction | 1.31807066 |
69 | MP0004264_abnormal_extraembryonic_tissu | 1.30584961 |
70 | MP0003868_abnormal_feces_composition | 1.30419705 |
71 | MP0003252_abnormal_bile_duct | 1.29678447 |
72 | MP0001764_abnormal_homeostasis | 1.29451030 |
73 | MP0002249_abnormal_larynx_morphology | 1.27758832 |
74 | MP0000733_abnormal_muscle_development | 1.27554057 |
75 | MP0001440_abnormal_grooming_behavior | 1.26303904 |
76 | MP0000427_abnormal_hair_cycle | 1.25124861 |
77 | MP0002822_catalepsy | 1.23054832 |
78 | MP0002734_abnormal_mechanical_nocicepti | 1.22079984 |
79 | * MP0003315_abnormal_perineum_morphology | 1.18672457 |
80 | MP0003941_abnormal_skin_development | 1.17834553 |
81 | MP0009379_abnormal_foot_pigmentation | 1.17743611 |
82 | MP0002067_abnormal_sensory_capabilities | 1.17615238 |
83 | MP0000750_abnormal_muscle_regeneration | 1.17255079 |
84 | MP0001486_abnormal_startle_reflex | 1.17197403 |
85 | MP0002108_abnormal_muscle_morphology | 1.17185895 |
86 | MP0002909_abnormal_adrenal_gland | 1.14682631 |
87 | MP0003329_amyloid_beta_deposits | 1.09102162 |
88 | MP0005646_abnormal_pituitary_gland | 1.08490139 |
89 | MP0002733_abnormal_thermal_nociception | 1.05708655 |
90 | MP0006138_congestive_heart_failure | 1.04922133 |
91 | MP0001177_atelectasis | 1.04783694 |
92 | MP0000230_abnormal_systemic_arterial | 1.04239171 |
93 | MP0002118_abnormal_lipid_homeostasis | 1.02635812 |
94 | MP0002653_abnormal_ependyma_morphology | 1.00382694 |
95 | MP0004087_abnormal_muscle_fiber | 1.00316856 |
96 | MP0004858_abnormal_nervous_system | 0.98909668 |
97 | MP0001970_abnormal_pain_threshold | 0.98381875 |
98 | MP0001188_hyperpigmentation | 0.95328595 |
99 | MP0008874_decreased_physiological_sensi | 0.94992759 |
100 | MP0005666_abnormal_adipose_tissue | 0.94857137 |
101 | MP0004924_abnormal_behavior | 0.94694621 |
102 | MP0005386_behavior/neurological_phenoty | 0.94694621 |
103 | MP0001756_abnormal_urination | 0.93729790 |
104 | MP0002060_abnormal_skin_morphology | 0.91194780 |
105 | MP0001348_abnormal_lacrimal_gland | 0.91166255 |
106 | MP0000604_amyloidosis | 0.89441884 |
107 | MP0001944_abnormal_pancreas_morphology | 0.89344723 |
108 | MP0002184_abnormal_innervation | 0.88311644 |
109 | MP0010630_abnormal_cardiac_muscle | 0.88174714 |
110 | MP0010368_abnormal_lymphatic_system | 0.86634340 |
111 | MP0002971_abnormal_brown_adipose | 0.84675345 |
112 | * MP0000538_abnormal_urinary_bladder | 0.84567845 |
113 | MP0004484_altered_response_of | 0.84551826 |
114 | MP0003879_abnormal_hair_cell | 0.83651759 |
115 | MP0005334_abnormal_fat_pad | 0.83340937 |
116 | * MP0005636_abnormal_mineral_homeostasis | 0.83183622 |
117 | MP0003045_fibrosis | 0.82960688 |
118 | * MP0002557_abnormal_social/conspecific_i | 0.82875847 |
119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82826215 |
120 | MP0004084_abnormal_cardiac_muscle | 0.81874684 |
121 | MP0004147_increased_porphyrin_level | 0.81699663 |
122 | MP0001485_abnormal_pinna_reflex | 0.79362114 |
123 | MP0005187_abnormal_penis_morphology | 0.78494473 |
124 | MP0005375_adipose_tissue_phenotype | 0.78139634 |
125 | MP0002269_muscular_atrophy | 0.77675911 |
126 | MP0001502_abnormal_circadian_rhythm | 0.77313984 |
127 | MP0002088_abnormal_embryonic_growth/wei | 0.76480215 |
128 | MP0000759_abnormal_skeletal_muscle | 0.75920717 |
129 | MP0001299_abnormal_eye_distance/ | 0.75743949 |
130 | MP0003633_abnormal_nervous_system | 0.75376423 |
131 | MP0010771_integument_phenotype | 0.75061644 |
132 | MP0003984_embryonic_growth_retardation | 0.75002391 |
133 | * MP0000627_abnormal_mammary_gland | 0.74435038 |
134 | MP0002168_other_aberrant_phenotype | 0.74247790 |
135 | MP0002896_abnormal_bone_mineralization | 0.74142570 |
136 | MP0002295_abnormal_pulmonary_circulatio | 0.74020155 |
137 | MP0001346_abnormal_lacrimal_gland | 0.73820447 |
138 | * MP0004036_abnormal_muscle_relaxation | 0.73530316 |
139 | MP0003638_abnormal_response/metabolism_ | 0.72484225 |
140 | MP0000003_abnormal_adipose_tissue | 0.72037785 |
141 | MP0002069_abnormal_eating/drinking_beha | 0.71756825 |
142 | MP0002078_abnormal_glucose_homeostasis | 0.71659803 |
143 | MP0002160_abnormal_reproductive_system | 0.71099601 |
144 | MP0000467_abnormal_esophagus_morphology | 0.70623477 |
145 | MP0003011_delayed_dark_adaptation | 0.70075336 |
146 | MP0008872_abnormal_physiological_respon | 0.70010470 |
147 | MP0003959_abnormal_lean_body | 0.69726681 |
148 | MP0005369_muscle_phenotype | 0.69568258 |
149 | MP0009643_abnormal_urine_homeostasis | 0.69533757 |
150 | MP0005620_abnormal_muscle_contractility | 0.68218800 |
151 | MP0008569_lethality_at_weaning | 0.67298833 |
152 | MP0001666_abnormal_nutrient_absorption | 0.67291612 |
153 | MP0002090_abnormal_vision | 0.66731595 |
154 | MP0009250_abnormal_appendicular_skeleto | 0.66673150 |
155 | MP0009384_cardiac_valve_regurgitation | 0.66433374 |
156 | MP0005448_abnormal_energy_balance | 0.64480871 |
157 | MP0001881_abnormal_mammary_gland | 0.63039481 |
158 | MP0000266_abnormal_heart_morphology | 0.61302251 |
159 | MP0004085_abnormal_heartbeat | 0.60195607 |
160 | MP0005330_cardiomyopathy | 0.59865860 |
161 | MP0003953_abnormal_hormone_level | 0.58574176 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 5.32248972 |
2 | Sparse lateral eyebrow (HP:0005338) | 5.09385232 |
3 | Abnormality of the 1st metacarpal (HP:0010009) | 4.74989454 |
4 | Neonatal hypoglycemia (HP:0001998) | 4.61011578 |
5 | Short 1st metacarpal (HP:0010034) | 4.14105031 |
6 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 4.14105031 |
7 | Hyperventilation (HP:0002883) | 4.10280134 |
8 | Septate vagina (HP:0001153) | 3.87418615 |
9 | Broad face (HP:0000283) | 3.78930558 |
10 | Short phalanx of the thumb (HP:0009660) | 3.75551910 |
11 | Overgrowth (HP:0001548) | 3.75138481 |
12 | Oligomenorrhea (HP:0000876) | 3.65351374 |
13 | Abnormality of the parathyroid morphology (HP:0011766) | 3.62534500 |
14 | Flat acetabular roof (HP:0003180) | 3.60640139 |
15 | Abnormality of carpal bone ossification (HP:0006257) | 3.50039505 |
16 | Atonic seizures (HP:0010819) | 3.37169684 |
17 | Shallow orbits (HP:0000586) | 3.36171541 |
18 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.31117495 |
19 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.30995812 |
20 | Lip pit (HP:0100267) | 3.28421729 |
21 | Focal seizures (HP:0007359) | 3.24205744 |
22 | Abnormal tarsal ossification (HP:0008369) | 3.19555915 |
23 | Absence seizures (HP:0002121) | 3.17282924 |
24 | Obstructive sleep apnea (HP:0002870) | 3.10762868 |
25 | Abnormality of the phalanges of the hallux (HP:0010057) | 3.10140169 |
26 | Abnormal hand bone ossification (HP:0010660) | 3.08978632 |
27 | Myokymia (HP:0002411) | 3.05838415 |
28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.04672223 |
29 | Germ cell neoplasia (HP:0100728) | 2.98132369 |
30 | Abnormality of the fingertips (HP:0001211) | 2.92377758 |
31 | Aplasia involving bones of the extremities (HP:0009825) | 2.87932297 |
32 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.87932297 |
33 | Aplasia of the phalanges of the hand (HP:0009802) | 2.87932297 |
34 | Abnormal ossification of hand bones (HP:0005921) | 2.81999348 |
35 | Action tremor (HP:0002345) | 2.81199642 |
36 | Advanced eruption of teeth (HP:0006288) | 2.80681594 |
37 | Complement deficiency (HP:0004431) | 2.76816606 |
38 | Anal stenosis (HP:0002025) | 2.75609054 |
39 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.71068977 |
40 | Neoplasm of the adrenal cortex (HP:0100641) | 2.65077802 |
41 | Depressed nasal tip (HP:0000437) | 2.63892283 |
42 | Generalized tonic-clonic seizures (HP:0002069) | 2.61486910 |
43 | Cervical subluxation (HP:0003308) | 2.60235475 |
44 | Febrile seizures (HP:0002373) | 2.58221342 |
45 | Acanthosis nigricans (HP:0000956) | 2.57488312 |
46 | Hyperglycinuria (HP:0003108) | 2.55809280 |
47 | Dialeptic seizures (HP:0011146) | 2.53641147 |
48 | Ketosis (HP:0001946) | 2.53198542 |
49 | Deep venous thrombosis (HP:0002625) | 2.52694160 |
50 | Macroorchidism (HP:0000053) | 2.52199293 |
51 | Spontaneous abortion (HP:0005268) | 2.50432722 |
52 | Exercise-induced myalgia (HP:0003738) | 2.49447734 |
53 | Ketoacidosis (HP:0001993) | 2.46732579 |
54 | Hypophosphatemic rickets (HP:0004912) | 2.42748359 |
55 | Abnormal eating behavior (HP:0100738) | 2.35949134 |
56 | Fibular aplasia (HP:0002990) | 2.34534310 |
57 | Abnormal foot bone ossification (HP:0010675) | 2.33346254 |
58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32422454 |
59 | Abnormality of glycine metabolism (HP:0010895) | 2.32422454 |
60 | Laryngomalacia (HP:0001601) | 2.28146635 |
61 | Abnormality of the nasal septum (HP:0000419) | 2.27697845 |
62 | Aplasia of the musculature (HP:0100854) | 2.25512096 |
63 | Prolonged partial thromboplastin time (HP:0003645) | 2.25114960 |
64 | Hyperglycinemia (HP:0002154) | 2.24932430 |
65 | Myotonia (HP:0002486) | 2.24164229 |
66 | 11 pairs of ribs (HP:0000878) | 2.22852777 |
67 | Neonatal death (HP:0003811) | 2.20220992 |
68 | Xanthomatosis (HP:0000991) | 2.17988300 |
69 | Short nail (HP:0001799) | 2.17836458 |
70 | Hypoplasia of the odontoid process (HP:0003311) | 2.16959949 |
71 | Short humerus (HP:0005792) | 2.16761346 |
72 | Scanning speech (HP:0002168) | 2.16372214 |
73 | Hyperkalemia (HP:0002153) | 2.15055608 |
74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.14226364 |
75 | Glossoptosis (HP:0000162) | 2.13177444 |
76 | Hyperthyroidism (HP:0000836) | 2.11745573 |
77 | Polyphagia (HP:0002591) | 2.11543074 |
78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.10381961 |
79 | Infantile muscular hypotonia (HP:0008947) | 2.10274679 |
80 | Progressive cerebellar ataxia (HP:0002073) | 2.08694226 |
81 | Hyporeflexia of lower limbs (HP:0002600) | 2.08570333 |
82 | Dysmetric saccades (HP:0000641) | 2.05511224 |
83 | Amelogenesis imperfecta (HP:0000705) | 2.05161178 |
84 | Precocious puberty (HP:0000826) | 2.05115750 |
85 | Visual hallucinations (HP:0002367) | 2.01057189 |
86 | Epileptic encephalopathy (HP:0200134) | 2.00983346 |
87 | Excessive salivation (HP:0003781) | 2.00030145 |
88 | Drooling (HP:0002307) | 2.00030145 |
89 | Type 1 muscle fiber predominance (HP:0003803) | 1.99724816 |
90 | Cardiovascular calcification (HP:0011915) | 1.99364106 |
91 | Fair hair (HP:0002286) | 1.97318771 |
92 | Broad-based gait (HP:0002136) | 1.97014601 |
93 | Broad metatarsal (HP:0001783) | 1.96959507 |
94 | Abnormality of the Achilles tendon (HP:0005109) | 1.96826583 |
95 | Long eyelashes (HP:0000527) | 1.95358092 |
96 | Exotropia (HP:0000577) | 1.91338701 |
97 | Increased circulating renin level (HP:0000848) | 1.89276038 |
98 | Aortic aneurysm (HP:0004942) | 1.89272807 |
99 | Gout (HP:0001997) | 1.87477086 |
100 | Hypoventilation (HP:0002791) | 1.86433713 |
101 | Hypoalphalipoproteinemia (HP:0003233) | 1.85729641 |
102 | Increased connective tissue (HP:0009025) | 1.85315007 |
103 | Epidermoid cyst (HP:0200040) | 1.84456932 |
104 | Aplastic anemia (HP:0001915) | 1.84036871 |
105 | Choanal stenosis (HP:0000452) | 1.83474770 |
106 | Blue irides (HP:0000635) | 1.83366836 |
107 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.83100770 |
108 | Broad nasal tip (HP:0000455) | 1.82845014 |
109 | Vascular calcification (HP:0004934) | 1.82812464 |
110 | Dysdiadochokinesis (HP:0002075) | 1.82767145 |
111 | Abnormal social behavior (HP:0012433) | 1.81578802 |
112 | Impaired social interactions (HP:0000735) | 1.81578802 |
113 | Blue sclerae (HP:0000592) | 1.81213934 |
114 | Conjugated hyperbilirubinemia (HP:0002908) | 1.81114714 |
115 | Anxiety (HP:0000739) | 1.81060408 |
116 | Abnormality of purine metabolism (HP:0004352) | 1.80499641 |
117 | Status epilepticus (HP:0002133) | 1.79315909 |
118 | Narrow palate (HP:0000189) | 1.79150791 |
119 | Hypokalemic alkalosis (HP:0001949) | 1.78379223 |
120 | Popliteal pterygium (HP:0009756) | 1.77459381 |
121 | Hyperlipoproteinemia (HP:0010980) | 1.76202318 |
122 | Right ventricular cardiomyopathy (HP:0011663) | 1.76087833 |
123 | Intrahepatic cholestasis (HP:0001406) | 1.75313853 |
124 | Hypoplastic nipples (HP:0002557) | 1.74500747 |
125 | Narrow nasal bridge (HP:0000446) | 1.73224452 |
126 | Back pain (HP:0003418) | 1.73097719 |
127 | Hypomagnesemia (HP:0002917) | 1.72717244 |
128 | Cerebral inclusion bodies (HP:0100314) | 1.72353254 |
129 | Shawl scrotum (HP:0000049) | 1.71537115 |
130 | Achilles tendon contracture (HP:0001771) | 1.71290415 |
131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.70743828 |
132 | Delayed CNS myelination (HP:0002188) | 1.68930339 |
133 | Abnormality of the odontoid process (HP:0003310) | 1.68400764 |
134 | Facial diplegia (HP:0001349) | 1.68027457 |
135 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67703814 |
136 | * Gonadotropin excess (HP:0000837) | 1.67396479 |
137 | Intention tremor (HP:0002080) | 1.66710116 |
138 | Ulnar claw (HP:0001178) | 1.66092374 |
139 | Bronchomalacia (HP:0002780) | 1.65762625 |
140 | Myocardial infarction (HP:0001658) | 1.65729988 |
141 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65706562 |
142 | Abnormal cartilage morphology (HP:0002763) | 1.65403189 |
143 | Hypothermia (HP:0002045) | 1.64305019 |
144 | Metabolic alkalosis (HP:0200114) | 1.63962695 |
145 | Impaired smooth pursuit (HP:0007772) | 1.62437590 |
146 | Hyperactive renin-angiotensin system (HP:0000841) | 1.62096978 |
147 | Amblyopia (HP:0000646) | 1.62070960 |
148 | Dysmetria (HP:0001310) | 1.62067093 |
149 | Long palpebral fissure (HP:0000637) | 1.61669206 |
150 | * Hyperpituitarism (HP:0010514) | 1.61260769 |
151 | Distal arthrogryposis (HP:0005684) | 1.59950871 |
152 | Vertebral clefting (HP:0008428) | 1.59940924 |
153 | Hyperuricemia (HP:0002149) | 1.59719573 |
154 | Increased purine levels (HP:0004368) | 1.59719573 |
155 | Abnormality of complement system (HP:0005339) | 1.59355692 |
156 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.59044839 |
157 | Polycystic kidney dysplasia (HP:0000113) | 1.58747866 |
158 | Hyperammonemia (HP:0001987) | 1.57713112 |
159 | Hypopigmentation of the fundus (HP:0007894) | 1.57638483 |
160 | Neoplasm of the adrenal gland (HP:0100631) | 1.57337134 |
161 | Short hallux (HP:0010109) | 1.57078451 |
162 | Generalized hypopigmentation of hair (HP:0011358) | 1.56991243 |
163 | Gaze-evoked nystagmus (HP:0000640) | 1.56090088 |
164 | Asymmetric septal hypertrophy (HP:0001670) | 1.55623574 |
165 | Rickets (HP:0002748) | 1.55602915 |
166 | Seborrheic dermatitis (HP:0001051) | 1.55506228 |
167 | Growth hormone excess (HP:0000845) | 1.55312774 |
168 | Spinal cord compression (HP:0002176) | 1.54799159 |
169 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.54723013 |
170 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.54149248 |
171 | Renal cortical cysts (HP:0000803) | 1.51654035 |
172 | Exercise-induced muscle cramps (HP:0003710) | 1.51530742 |
173 | Death in childhood (HP:0003819) | 1.51252122 |
174 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.50789672 |
175 | Abnormality of the 2nd finger (HP:0004100) | 1.50348527 |
176 | Lymphangioma (HP:0100764) | 1.49959902 |
177 | Relative macrocephaly (HP:0004482) | 1.49503583 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRKD3 | 5.00339621 |
2 | EEF2K | 4.15051496 |
3 | TAOK1 | 4.11913069 |
4 | TRIB3 | 3.80708002 |
5 | CASK | 3.74913338 |
6 | EPHA4 | 3.24961001 |
7 | PIM2 | 2.93903953 |
8 | OXSR1 | 2.92135111 |
9 | NTRK3 | 2.90343350 |
10 | PRKD2 | 2.86219936 |
11 | STK39 | 2.77755757 |
12 | AKT3 | 2.66631188 |
13 | MAP3K4 | 2.63814387 |
14 | MAP3K12 | 2.32951774 |
15 | MAP2K4 | 2.18460591 |
16 | FRK | 2.09375102 |
17 | RIPK4 | 1.94619792 |
18 | INSRR | 1.92963467 |
19 | MARK2 | 1.91761942 |
20 | MAP2K7 | 1.91162813 |
21 | MYLK | 1.88863703 |
22 | SMG1 | 1.87152103 |
23 | PKN2 | 1.80357266 |
24 | DAPK2 | 1.56487414 |
25 | NTRK1 | 1.56259962 |
26 | BCKDK | 1.54425903 |
27 | MTOR | 1.48538238 |
28 | ICK | 1.47027034 |
29 | PDK2 | 1.43959678 |
30 | CDK12 | 1.38235162 |
31 | MST1R | 1.37007751 |
32 | SIK1 | 1.34265370 |
33 | MINK1 | 1.33811672 |
34 | FGFR2 | 1.33667872 |
35 | BMPR2 | 1.31146834 |
36 | PRKCI | 1.26734874 |
37 | MAP3K2 | 1.26177998 |
38 | PIK3CA | 1.20376081 |
39 | PDK3 | 1.19618658 |
40 | PDK4 | 1.19618658 |
41 | PAK2 | 1.19505943 |
42 | SGK2 | 1.19290120 |
43 | MAP3K9 | 1.18515004 |
44 | LMTK2 | 1.17897159 |
45 | GRK5 | 1.17090259 |
46 | WNK3 | 1.16667155 |
47 | WNK4 | 1.16291403 |
48 | MST4 | 1.14731410 |
49 | PLK2 | 1.10821155 |
50 | CAMK1G | 1.10642313 |
51 | ARAF | 1.09526834 |
52 | RAF1 | 1.07544177 |
53 | LATS1 | 1.07296666 |
54 | MAPKAPK3 | 1.07036747 |
55 | MAP3K7 | 1.05853857 |
56 | PTK2B | 1.03081651 |
57 | PHKG1 | 1.02609876 |
58 | PHKG2 | 1.02609876 |
59 | STK38 | 1.01956327 |
60 | SGK223 | 1.00669449 |
61 | SGK494 | 1.00669449 |
62 | ERN1 | 0.98317133 |
63 | * FER | 0.95734497 |
64 | SGK3 | 0.94736332 |
65 | CAMK1D | 0.94279626 |
66 | PIK3CG | 0.93636246 |
67 | CAMK2A | 0.89045936 |
68 | TAF1 | 0.88088777 |
69 | PRKAA1 | 0.86364852 |
70 | EIF2AK1 | 0.85098074 |
71 | BRSK2 | 0.84635259 |
72 | IRAK2 | 0.84587533 |
73 | MUSK | 0.83869516 |
74 | PRKCG | 0.79749088 |
75 | * CDK5 | 0.79540831 |
76 | PRKCE | 0.78486407 |
77 | SCYL2 | 0.78345073 |
78 | EPHA2 | 0.77899551 |
79 | PDGFRA | 0.76765560 |
80 | DMPK | 0.76271869 |
81 | WNK1 | 0.75768301 |
82 | DAPK1 | 0.72367778 |
83 | LATS2 | 0.72044885 |
84 | CAMKK2 | 0.70918055 |
85 | RET | 0.69581706 |
86 | BCR | 0.66588403 |
87 | SGK1 | 0.64820379 |
88 | PINK1 | 0.64365178 |
89 | PAK3 | 0.63624167 |
90 | TTN | 0.62758307 |
91 | CAMK2G | 0.62464741 |
92 | MAPK12 | 0.62442797 |
93 | MAP2K1 | 0.62093167 |
94 | CAMK2B | 0.60545643 |
95 | ILK | 0.60524062 |
96 | MAPK13 | 0.58778800 |
97 | NEK6 | 0.58567834 |
98 | CDK19 | 0.58116665 |
99 | TNIK | 0.57857319 |
100 | FGFR3 | 0.57444215 |
101 | PDPK1 | 0.57223167 |
102 | CAMKK1 | 0.56868416 |
103 | PRKD1 | 0.56197361 |
104 | GRK7 | 0.55870253 |
105 | PDK1 | 0.55561112 |
106 | MAPKAPK5 | 0.55515309 |
107 | BRD4 | 0.55454546 |
108 | PRKCH | 0.55286746 |
109 | ADRBK1 | 0.54784725 |
110 | PRPF4B | 0.53965788 |
111 | GRK1 | 0.52825620 |
112 | JAK1 | 0.52282671 |
113 | BRAF | 0.51871114 |
114 | IRAK3 | 0.50977788 |
115 | KSR2 | 0.50903040 |
116 | CAMK1 | 0.50093356 |
117 | EPHB2 | 0.50063912 |
118 | PRKCZ | 0.49820515 |
119 | ROCK2 | 0.49702199 |
120 | TRPM7 | 0.49591920 |
121 | PRKCQ | 0.48829872 |
122 | MAP3K13 | 0.48511428 |
123 | OBSCN | 0.48504890 |
124 | RPS6KA2 | 0.48326771 |
125 | ADRBK2 | 0.48149571 |
126 | CDK9 | 0.46211231 |
127 | DYRK1B | 0.45885550 |
128 | NME1 | 0.45768916 |
129 | CAMK2D | 0.44042112 |
130 | GSK3A | 0.42166250 |
131 | ROCK1 | 0.41645778 |
132 | MAPK7 | 0.40160445 |
133 | PNCK | 0.38711455 |
134 | PRKAA2 | 0.38190046 |
135 | RPS6KB2 | 0.37989438 |
136 | JAK2 | 0.37437132 |
137 | PRKACA | 0.37090894 |
138 | NEK9 | 0.35922297 |
139 | MAPK10 | 0.35792689 |
140 | TESK1 | 0.35044457 |
141 | PTK2 | 0.35005684 |
142 | CHUK | 0.33298805 |
143 | PDGFRB | 0.33134016 |
144 | AKT2 | 0.33080995 |
145 | CSNK1E | 0.33079520 |
146 | GSK3B | 0.30129686 |
147 | TESK2 | 0.30056272 |
148 | STK11 | 0.27413888 |
149 | CAMK4 | 0.25106329 |
150 | * MAPK8 | 0.24974157 |
151 | RPS6KL1 | 0.24922284 |
152 | RPS6KC1 | 0.24922284 |
153 | RPS6KA6 | 0.19092639 |
154 | PRKDC | 0.18951674 |
155 | * AKT1 | 0.18259937 |
156 | RPS6KB1 | 0.17078054 |
157 | * MAPK14 | 0.16177347 |
158 | CSNK2A2 | 0.15950531 |
159 | STK38L | 0.15818466 |
160 | * CDK1 | 0.15544121 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.39832181 |
2 | Lysine degradation_Homo sapiens_hsa00310 | 2.33457268 |
3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.31820981 |
4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.14415502 |
5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09409469 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06479561 |
7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.79617907 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.74953962 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73472288 |
10 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.69850394 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68909762 |
12 | Renin secretion_Homo sapiens_hsa04924 | 1.62389890 |
13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.58544959 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56538175 |
15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56111741 |
16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55158291 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53663063 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51772046 |
19 | Salivary secretion_Homo sapiens_hsa04970 | 1.51706503 |
20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50621586 |
21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49098608 |
22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48829003 |
23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.48510934 |
24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.45621455 |
25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.44794650 |
26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40362205 |
27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40076178 |
28 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.34504969 |
29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.31360125 |
30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.29075325 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.25944324 |
32 | Morphine addiction_Homo sapiens_hsa05032 | 1.25818162 |
33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25341830 |
34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25326858 |
35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.22994021 |
36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21811581 |
37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21221965 |
38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20763478 |
39 | Taste transduction_Homo sapiens_hsa04742 | 1.19575110 |
40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19337776 |
41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17254820 |
42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16771095 |
43 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16755082 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15287047 |
45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15123492 |
46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13540893 |
47 | Insulin resistance_Homo sapiens_hsa04931 | 1.10821604 |
48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04942289 |
49 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.03771988 |
50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.03509686 |
51 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.02967981 |
52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02648677 |
53 | Bile secretion_Homo sapiens_hsa04976 | 1.02542388 |
54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.02018640 |
55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01593241 |
56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99715909 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99382806 |
58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97608984 |
59 | Mineral absorption_Homo sapiens_hsa04978 | 0.97480369 |
60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95483886 |
61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95266912 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94690484 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94189661 |
64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93910447 |
65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93691603 |
66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93678528 |
67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92766532 |
68 | * Prostate cancer_Homo sapiens_hsa05215 | 0.92334507 |
69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91501855 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91160408 |
71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88686288 |
72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88378355 |
73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86158067 |
74 | Long-term depression_Homo sapiens_hsa04730 | 0.86092539 |
75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86088275 |
76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85198637 |
77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84991523 |
78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84273906 |
79 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82291825 |
80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80987380 |
81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80610450 |
82 | Insulin secretion_Homo sapiens_hsa04911 | 0.79777472 |
83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78324497 |
84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78268910 |
85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78182090 |
86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77699934 |
87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76277217 |
88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75663092 |
89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75426959 |
90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75013862 |
91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73588906 |
92 | Prion diseases_Homo sapiens_hsa05020 | 0.72578520 |
93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.72271964 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69051644 |
95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67896073 |
96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67590449 |
97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66829054 |
98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66710335 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66257702 |
100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65865740 |
101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64708872 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64570591 |
103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64457745 |
104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62368095 |
105 | Tight junction_Homo sapiens_hsa04530 | 0.61765210 |
106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61165529 |
107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60813599 |
108 | Melanogenesis_Homo sapiens_hsa04916 | 0.60403621 |
109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60003435 |
110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57136605 |
111 | ABC transporters_Homo sapiens_hsa02010 | 0.57111393 |
112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56494177 |
113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54412279 |
114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51574133 |
115 | Gap junction_Homo sapiens_hsa04540 | 0.49053363 |
116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48514989 |
117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48035420 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47506041 |
119 | Adherens junction_Homo sapiens_hsa04520 | 0.45868515 |
120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44184263 |
121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41431699 |
122 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40703789 |
123 | Glioma_Homo sapiens_hsa05214 | 0.40559449 |
124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40299367 |
125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40010027 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39980969 |
127 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39765692 |
128 | Axon guidance_Homo sapiens_hsa04360 | 0.39088032 |
129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38672843 |
130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38236782 |
131 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38209172 |
132 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37486020 |
133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34398149 |
134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33267927 |
135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33151228 |
136 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32147209 |
137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28637834 |
138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27882965 |
139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25358200 |
140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24273487 |
141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24047390 |
142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.23603417 |
143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23551800 |
144 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23538922 |